KR20240139058A - 흉선 기질 림포포이에틴에 결합하는 단백질 z 변이체 및 이의 의학적 용도 - Google Patents

흉선 기질 림포포이에틴에 결합하는 단백질 z 변이체 및 이의 의학적 용도 Download PDF

Info

Publication number
KR20240139058A
KR20240139058A KR1020247025767A KR20247025767A KR20240139058A KR 20240139058 A KR20240139058 A KR 20240139058A KR 1020247025767 A KR1020247025767 A KR 1020247025767A KR 20247025767 A KR20247025767 A KR 20247025767A KR 20240139058 A KR20240139058 A KR 20240139058A
Authority
KR
South Korea
Prior art keywords
tslp
sequence
seq
binding
binding polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247025767A
Other languages
English (en)
Korean (ko)
Inventor
안나 에드바르드손
린드비 구드문드스도테르
시아바쉬 키자니
수잔 클린트
Original Assignee
애피바디 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애피바디 에이비 filed Critical 애피바디 에이비
Publication of KR20240139058A publication Critical patent/KR20240139058A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020247025767A 2022-02-08 2023-02-08 흉선 기질 림포포이에틴에 결합하는 단백질 z 변이체 및 이의 의학적 용도 Pending KR20240139058A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22155646 2022-02-08
EP22155646.7 2022-02-08
PCT/EP2023/053030 WO2023152144A1 (en) 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use

Publications (1)

Publication Number Publication Date
KR20240139058A true KR20240139058A (ko) 2024-09-20

Family

ID=80682629

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247025767A Pending KR20240139058A (ko) 2022-02-08 2023-02-08 흉선 기질 림포포이에틴에 결합하는 단백질 z 변이체 및 이의 의학적 용도

Country Status (10)

Country Link
EP (1) EP4476247A1 (https=)
JP (1) JP2025506381A (https=)
KR (1) KR20240139058A (https=)
CN (1) CN118632866A (https=)
AR (1) AR128475A1 (https=)
AU (1) AU2023218534A1 (https=)
CA (1) CA3251231A1 (https=)
IL (1) IL314458A (https=)
MX (1) MX2024009732A (https=)
WO (1) WO2023152144A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190863B1 (en) 2007-07-31 2015-09-02 Affibody AB New albumin binding compositions, methods and uses
ES2373832T3 (es) 2007-12-19 2012-02-09 Affibody Ab Polipéptido derivado de proteína a y capaz de unirse a pdgf.
CN103003296A (zh) 2010-07-09 2013-03-27 阿菲博迪公司 多肽
WO2014048977A1 (en) 2012-09-25 2014-04-03 Affibody Ab Albumin binding polzpeptide
KR102399024B1 (ko) 2014-06-13 2022-05-17 애피바디 에이비 신규 폴리펩티드
EP3245224B1 (en) * 2015-01-12 2020-07-15 Affibody AB Il-17a-binding polypeptides
CN108290931A (zh) 2015-10-30 2018-07-17 阿菲博迪公司 对pd-l1具有亲和力的新的多肽
WO2021089695A1 (en) * 2019-11-05 2021-05-14 Affibody Ab Polypeptides

Also Published As

Publication number Publication date
AR128475A1 (es) 2024-05-15
JP2025506381A (ja) 2025-03-11
WO2023152144A1 (en) 2023-08-17
CA3251231A1 (en) 2023-08-17
EP4476247A1 (en) 2024-12-18
MX2024009732A (es) 2024-08-19
IL314458A (en) 2024-09-01
AU2023218534A1 (en) 2024-07-11
CN118632866A (zh) 2024-09-10

Similar Documents

Publication Publication Date Title
CN105612180B (zh) 经靶向修饰的il-1家族成员
EP2086998B1 (en) Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof
WO2021244089A1 (zh) 新型冠状病毒（sars-cov-2）刺突蛋白结合分子及其应用
CN105555310B (zh) 一种提高蛋白血清半衰期的组合物和方法
CN114981300B (zh) 包含靶向TNFα和IL-23的免疫球蛋白单个可变结构域的多肽
RU2749712C2 (ru) IL-17A-связывающие полипептиды
TW201643179A (zh) Ｔｓｌｐ結合蛋白
JP2013518853A (ja) 血清アルブミンと結合することが可能なペプチド並びにこれを含む化合物、構築物及びポリペプチド
JP2015516813A5 (https=)
KR20100098697A (ko) 폐 전달을 위한 조성물
TW201444867A (zh) 抗ｔｎｆ－抗ｉｌ－１７雙特異性抗體
KR20140129163A (ko) 인간 보체 c5에 결합하는 폴리펩티드
US20200385434A1 (en) Coversin variants lacking c5 binding
KR20200015601A (ko) Mmp13 결합성 면역글로불린
US20250066451A1 (en) Il-ir-i binding polypeptide
JP2020523987A (ja) 半減期延長ポリペプチドを有する融合タンパク質
WO2023035272A1 (zh) 一种il17抗体及其制备方法和应用
CN106488930B (zh) 新型多肽
CN117279941A (zh) Vegfa结合分子
JP2026016388A (ja) 血清アルブミン結合ナノボディ組成物、及びその使用方法
KR20240139058A (ko) 흉선 기질 림포포이에틴에 결합하는 단백질 z 변이체 및 이의 의학적 용도
WO2013166470A2 (en) Uses of cxcl17, a novel chemokine marker of human lung and gastrointestinal disease
US20220389066A1 (en) Polypeptides
EP2922560A1 (en) Polypeptide antagonists of human il-23 receptor for treatment of autoimmune diseases
CN118620057A (zh) Il-1r1胞外区多肽突变体及其用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240730

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application